Skip to search formSkip to main contentSkip to account menu

therasphere

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Outcomes of radioembolization for unresectable hepatocellular carcinoma in patients with marginal functional hepatic reserve.
Review
2013
Review
2013
Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres.
2013
2013
Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis?
RATIONAL AND OBJECTIVE Radioembolization with yttrium-90 microspheres is a therapy that is used for hepatic tumors. 20-30 μm… 
2013
2013
3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study.
PURPOSE The introduction of radioembolization with microspheres represents a significant step forward in the treatment of… 
Review
2009
Review
2009
Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
Review
2009
Review
2009
Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency… 
2009
2009
Treatment of Primary Liver Tumors with Yttrium-90 Microspheres (TheraSphere®) in High Risk Patients: Analysis of Survival and Toxicities
This retrospective study was undertaken to obtain information regarding the survival and toxicities after Yttrium-90 microspheres… 
Review
2008
Review
2008
Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy.
2005
2005
90 Y Microsphere (TheraSphere) Treatment for Unresectable Colorectal Cancer Metastases of the Liver: Response to Treatment at Targeted Doses of 135-150 Gy as Measured by ( 18 F)Fluorodeoxyglucose…
was correlated with response on [ 18 F]fluorodeoxyglucose (FDG) positron emission tomography (PET). Survival from first treatment… 
2004
2004
Advanced, unresectable hepatocellular carcinoma (HCC): responses and long-term survival after 90Yttrium microspheres (Therasphere) treatment in 80 patients.
4085 Background: The tumor responses, long-term survivals and toxicities are reported for a large group of U.S. patients (pts… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)